Alternatives to Progeny: a 2026 field guide for clinical pedigree software

Looking for an alternative to Progeny? Here's an honest field guide. Progeny is one of the longest-running clinical pedigree vendors — its core product traces back to 1996 and it has a real institutional footprint in clinical genetics. But it has also been cited in third-party reviews for rising pricing and an architectural heritage that predates modern cloud patterns. Teams consider alternatives at renewal, after headcount growth, or when they want modern surfaces (REST APIs, AI interpretation, MCP agents) that Progeny does not currently advertise.

This page is written as a field guide rather than a sales pitch. It covers five credible alternatives — Phenotips, TrakGene, FamGenix, Evagene, and QuickPed — and it tells you plainly where each fits and where each falls short. Evagene publishes this site, and we mark its gaps (cancer-risk breadth against FamGenix, HPO against Phenotips) as plainly as we mark its strengths.

Short version. If you need enterprise-scale clinical rigour with HPO phenotyping, Phenotips is the closest peer to Progeny. For modern FHIR-native integration, TrakGene. For cancer-risk breadth (BOADICEA v6, Tyrer-Cuzick v8, Gail, Claus, QRISK3), FamGenix. For modern pedigree-first work with AI, APIs, and programmatic access — plus free Alpha access — Evagene. QuickPed is a free academic Shiny app for research, not a clinical Progeny replacement.

Why teams look for alternatives to Progeny

The most common reason is cost. Progeny does not publish list pricing, and independent reviewers and procurement teams have repeatedly reported that its enterprise quotes have risen over recent renewal cycles. When cost rises faster than capability, renewal becomes a decision point. Teams who joined Progeny when it was the main viable choice now find a wider field of credible peers — some with published pricing, free tiers, or Alpha programmes that allow evaluation without a full procurement cycle.

The second reason is modernisation. Progeny was built in the late 1990s; its clinical core is mature and proven, but modern conveniences — a public REST API, webhooks for event-driven integration, an AI interpretation layer, MCP integration for AI agents, an embeddable pedigree viewer — are not among its advertised features. Services that want to build internal tools, connect a FHIR gateway, drive AI-assisted reporting, or embed pedigrees in patient portals often find it easier to build those on a newer platform. A third reason is simple workflow fit: some services are pedigree-first and find Progeny's full genetics suite broader than they need.

Five alternatives worth evaluating

Phenotips

Phenotips is the closest enterprise peer to Progeny in the clinical genetics space. It positions itself as a complete Genomic Health Record with Human Phenotype Ontology (HPO) at its core, EHR integration, and a large installed base (100,000+ patient records across 60+ countries per its homepage). It is particularly strong in undiagnosed rare disease diagnostics and phenotype-driven gene suggestion.

Where Phenotips fits: services considering an enterprise replacement for Progeny that want deeper HPO phenotyping and phenotype-to-gene capability. Where it falls short: like Progeny, Phenotips does not publish pricing and is enterprise sales-led, so it does not solve the procurement friction that drives some Progeny teams to evaluate alternatives. See our Phenotips vs Evagene comparison for detail.

TrakGene

TrakGene is a clinician-built clinical genetics platform with modern architecture and HL7 FHIR as first-class integration. Its public customer list includes NIH, NHS services, and Geisinger. The product covers pedigree drawing, clinical documentation, and EHR integration; its FHIR surface is genuinely attractive for services planning modern integration work.

Where TrakGene fits: clinical genetics services who want a pedigree-centred modern platform with FHIR integration and active clinician-driven product development. Where it falls short: as with Progeny and Phenotips, public pricing is not published and there is no free tier, so small-team evaluation still requires a sales conversation. If modernisation is the driver for your Progeny search, TrakGene is a serious candidate.

FamGenix

FamGenix stands out for its cancer-risk breadth: BOADICEA v6, Tyrer-Cuzick v8, Gail, Claus, and QRISK3 running simultaneously from one pedigree. It offers tiered pricing and a free Individual tier, which removes evaluation friction dramatically relative to any of the enterprise sales-led peers.

Where FamGenix fits: services whose Progeny use is dominated by hereditary cancer risk assessment, particularly breast, ovarian, and prostate risk. Where it falls short: FamGenix is not positioned as a broad genomic health record; AI interpretation, REST APIs, and MCP integration are not its focus. If your Progeny workflow extends well beyond cancer risk — cardiac genetics, reproductive genetics, undiagnosed rare disease — you may find FamGenix narrower than you need.

Evagene

Evagene is a browser-first clinical-grade pedigree platform built for precision medicine. Clinically it covers NSGC/ISCN standard notation with a gesture-drawing canvas, a 200+ disease catalogue with ICD-10 and OMIM annotation, BRCAPRO, MMRpro, and PancPRO from the BayesMendel suite, Mendelian inheritance calculators (AD/AR/XR), batch risk screening, a karyogram viewer, and consanguinity detection via Wright's coefficient — a set that matches Progeny's clinical rigour on the cancer-risk and monogenic axes while covering a broader inherited-disease surface.

Where Evagene differs from Progeny is the platform layer. AI interpretation uses bring-your-own-key (BYOK) LLMs — Anthropic Claude, OpenAI GPT — so clinical text goes directly to a provider you have risk-assessed, not through a vendor-hosted model. Analysis Templates codify a house style for AI-drafted reports. A scoped, rate-limited REST API, HMAC-SHA256 webhooks, an MCP server with 11 pedigree tools for Claude Desktop and Claude Code, and an embeddable pedigree viewer (iframe/SVG/JS) make Evagene programmable in ways Progeny is not.

Where Evagene falls short: it does not currently include BOADICEA or Tyrer-Cuzick (FamGenix leads there), and does not have Phenotips's HPO depth. It is currently in Alpha, with free access via waiting list; formal certifications should be confirmed at contract. For services leaving Progeny because they want modern surfaces without losing clinical rigour, Evagene is the intended fit. A deeper head-to-head will live at Progeny vs Evagene.

QuickPed

QuickPed is a free Shiny app from Magnus Vigeland's group at the University of Oslo, documented in a 2022 BMC Bioinformatics paper. It excels at pedigree construction, kinship and inbreeding coefficient calculation, and relatedness analysis — the classical academic research use cases.

Where QuickPed fits: academic researchers, forensic genetics teams, and consultants who need correct relatedness mathematics without a clinical suite. Where it falls short as a Progeny alternative: QuickPed is not a clinical platform. It does not carry disease annotation catalogues, cancer risk models, clinical reporting, EHR integration, or the governance features a clinical genetics service needs. For research augmentation of a clinical setup, useful; as a direct Progeny replacement, it is not.

Feature comparison matrix

The matrix summarises publicly advertised features across Progeny and the five alternatives. A tick means the feature is publicly documented. A dash means it is not publicly advertised; enterprise vendors often keep capabilities behind sales.

Compiled from publicly available product pages as of April 2026. "—" means not publicly advertised.

How to choose

Enterprise replacement with HPO depth. If your Progeny workflow includes undiagnosed rare disease and you want HPO phenotyping, Phenotips is the strongest peer.

Modern FHIR-native clinical genetics. TrakGene is the strongest fit for services whose priority is HL7 FHIR integration with a clinician-built modern platform.

Cancer-risk-dominated practice. FamGenix leads on simultaneous BOADICEA v6 + Tyrer-Cuzick v8 + Gail + Claus + QRISK3 coverage and offers the most straightforward evaluation path.

Modern agentic workflows and broad clinical coverage. Evagene combines BayesMendel risk (BRCAPRO, MMRpro, PancPRO), Mendelian inheritance calculators, batch screening, AI interpretation with BYOK LLMs, a REST API, an MCP server, and GEDCOM/23andMe interoperability. For Progeny services whose pain is modernisation as much as cost, Evagene is the intended fit.

Academic research augmentation. QuickPed for kinship mathematics and pedsuite-style research; not a Progeny replacement.

Frequently asked questions

Further reading

• Progeny vs Evagene: a detailed comparison
• Phenotips vs Evagene
• Clinical genetics pedigree tools: a field guide
• Hereditary cancer risk assessment
• Pedigree drawing software
• Mendelian inheritance calculator
• The Evagene platform layer (API, MCP, webhooks)